COMMUNIQUÉS West-GlobeNewswire

-
FDA Grants Pediatric Disease Designation for Mateon’s OT101
23/09/2019 -
Medtronic Announces FDA Approval and U.S. Launch of Next-Generation Evolut™ PRO+ TAVR System for Treatment of Symptomatic Severe Aortic Stenosis Patients
23/09/2019 -
Konica Minolta Healthcare CEO David Widmann to Share Insights on Creating Successful Strategic Partnerships at Health Connect South 2019 Annual Meeting
23/09/2019 -
Flexion Therapeutics Sponsors a Memorial to the Victims of the Opioid Crisis to Raise Awareness of the Tragic Consequences of the Opioid Epidemic Across the U.S.
23/09/2019 -
Onconova Therapeutics, Inc. Announces $3.4 Million Registered Direct Offering of Common Stock
23/09/2019 -
Transactions under Novozymes’ stock buyback program
23/09/2019 -
Abeona Therapeutics Provides Regulatory Update Ahead of Pivotal Phase 3 Clinical Trial for EB-101 in Recessive Dystrophic Epidermolysis Bullosa
23/09/2019 -
Cannabix Technologies Expands Marijuana Breathalyzer Portfolio with Licensing of UBC Technology for Workplace and Parental Use
23/09/2019 -
Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
23/09/2019 -
Pascal Biosciences Discovers Cannabinoids Activate the Major Histocompatibility Complex to Aid Cancer Treatment
23/09/2019 -
Mustang Bio Announces Phase 1 Clinical Trial Evaluating MB-105 for Prostate Stem Cell Antigen-Positive Castration-Resistant Prostate Cancer Enrolling Patients at City of Hope
23/09/2019 -
resTORbio to Present Findings on Investigational TORC1 Inhibitor RTB101 in Late-Breaking Session at IDWeek™ 2019
23/09/2019 -
Auransa Presents New Preclinical Data on AU-409, a Novel, AI-Derived Drug Candidate for the Treatment of Hepatocellular Carcinoma
23/09/2019 -
Novo Nordisk A/S – Share repurchase programme
23/09/2019 -
BeyondSpring’s Plinabulin Continues to Build on Superior Product Profile in Breast Cancer Trial for Neutropenia Prevention
23/09/2019 -
Passage Bio Grows Management Team with Chief Medical Officer and General Counsel Appointments
23/09/2019 -
Spring Bank to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference in New York, NY
23/09/2019 -
ORYZON Updates on New Activities
23/09/2019 -
Entera Bio Reports Positive Results from a Phase 2 PK/PD Study of Oral PTH (1-34) in Patients with Hypoparathyroidism
23/09/2019
Pages